Shares of Cepheid rose 12.3 percent for the five-day trading week ended Tuesday. Last week, the firm said that it had received European clearance and began marketing its Xpert MRSA/SA-Blood Cultures and Xpert MRSA/SA-Skin and Soft Tissue Infection SSTI molecular diagnostic tests.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.

In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.

Wired reports that 23andMe is trying to bolster its outside collaborations.